| ASSET | MONTH | % RETURN |
|---|---|---|
Ainos (AIMD) | April 2003 | 47,400% |
Pluri (PLUR) | April 2003 | 1,350% |
Champions Oncology (CSBR) | April 2003 | 400% |
Repro Med Systems (KRMD) | April 2003 | 366.67% |
Biocardia (BCDA) | April 2003 | 204% |
Encore Capital (ECPG) | April 2003 | 196.97% |
VirnetX (VHC) | April 2003 | 160% |
Curis (CRIS) | April 2003 | 160% |
Portage Biotech (PRTG) | April 2003 | 159.48% |
Natural Health Trend (NHTC) | April 2003 | 158.59% |
Cantaloupe (CTLP) | April 2003 | 127.27% |
Smith Micro Software (SMSI) | April 2003 | 127.27% |
AXT (AXTI) | April 2003 | 124.64% |
Arrowhead Pharmaceuticals (ARWR) | April 2003 | 114.29% |
CASI Pharmaceuticals (CASI) | April 2003 | 109.43% |
Durect (DRRX) | April 2003 | 109.29% |
Sono-Tek (SOTK) | April 2003 | 100% |
Axon Enterprise (AXON) | April 2003 | 89.94% |
Cassava Sciences (SAVA) | April 2003 | 89.41% |
Insmed (INSM) | April 2003 | 87.5% |
Stratasys (SSYS) | April 2003 | 84.44% |
U-Haul (UHAL) | April 2003 | 82.45% |
Sarepta Therapeutics (SRPT) | April 2003 | 82.03% |
Omnicell (OMCL) | April 2003 | 80.86% |
Braskem SA Class A (BAK) | April 2003 | 78.43% |
